Suppr超能文献

相似文献

2
Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1060-7. doi: 10.1164/rccm.201505-0894OC.
4
Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
Am J Respir Crit Care Med. 2016 Sep 1;194(5):568-76. doi: 10.1164/rccm.201512-2480OC.
5
Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
Eur Respir J. 2015 Dec;46(6):1589-1597. doi: 10.1183/13993003.02377-2014. Epub 2015 Nov 5.
6
Should we be screening for COPD? - looking through the lens of lung cancer screening.
Expert Rev Respir Med. 2023 Jul-Dec;17(9):753-771. doi: 10.1080/17476348.2023.2259800. Epub 2023 Oct 27.
7
The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
Int J Chron Obstruct Pulmon Dis. 2014 Dec 9;9:1357-63. doi: 10.2147/COPD.S61265. eCollection 2014.
8
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

引用本文的文献

5
Impaired lung function and lung cancer risk in 461 183 healthy individuals: a cohort study.
BMJ Open Respir Res. 2024 May 7;11(1):e001936. doi: 10.1136/bmjresp-2023-001936.
6
Lung cancer in patients who have never smoked - an emerging disease.
Nat Rev Clin Oncol. 2024 Feb;21(2):121-146. doi: 10.1038/s41571-023-00844-0. Epub 2024 Jan 9.
7
Clinical Adjuncts to Lung Cancer Screening: A Narrative Review.
Thorac Surg Clin. 2023 Nov;33(4):421-432. doi: 10.1016/j.thorsurg.2023.03.002. Epub 2023 May 12.
8
A Closer Look-Who Are We Screening for Lung Cancer?
Mayo Clin Proc Innov Qual Outcomes. 2023 May 3;7(3):171-177. doi: 10.1016/j.mayocpiqo.2023.04.002. eCollection 2023 Jun.
9
Lung Imaging in COPD Part 1: Clinical Usefulness.
Chest. 2023 Jul;164(1):69-84. doi: 10.1016/j.chest.2023.03.007. Epub 2023 Mar 11.

本文引用的文献

1
Lung Cancer Screening in Individuals with Chronic Obstructive Pulmonary Disease. Finding the Sweet Spot.
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1027-8. doi: 10.1164/rccm.201508-1594ED.
2
Mortality Reduction, Overdiagnosis, and the Benefit-to-Harm Ratio of Computed Tomography Screening.
Am J Respir Crit Care Med. 2015 Aug 1;192(3):398-9. doi: 10.1164/rccm.201504-0801LE.
3
Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1060-7. doi: 10.1164/rccm.201505-0894OC.
4
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Am J Respir Crit Care Med. 2015 May 15;191(10):1166-75. doi: 10.1164/rccm.201408-1475OC.
5
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition.
Eur Respir J. 2015 May;45(5):1258-72. doi: 10.1183/09031936.00135814. Epub 2015 Mar 5.
8
Airway basal cells. The "smoking gun" of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1355-62. doi: 10.1164/rccm.201408-1492PP.
9
Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit.
J Epidemiol Community Health. 2015 Feb;69(2):99-100. doi: 10.1136/jech-2014-204293. Epub 2014 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验